| ALV | Abelson leukemia virus; adeno-like virus; alveolar, alveolus; ascending lumbar vein; avian leukosis ... |
|---|---|
| SV | saphenous vein; sarcoma virus; satellite virus; selective vagotomy; semilunar valve; seminal vesicle... |
| DEV | Duck Embryo Vaccine |
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
| HDCV | Human Diploid Cell Vaccine; 인간 이배체 세포 백신 |
| diphtheria-tetanus-pertussis vaccine | A vaccine consisting of diphtheria toxoid, tetanus toxoid, and pertussis vaccine. It is usually given to infants three times at two-month intervals, generally at 2, 4, and 6 months of age. The vaccine protects against diphtheria, tetanus, and whooping cough. In most cases the vaccine causes only a temporary fever and discomfort, but in a few cases serious neurological side effects have been observed. (12 Dec 1998) |
|---|---|
| DTP vaccine | A vaccination administered to infants for protection against diphtheria, pertussis (whooping cough) and tetanus. Vaccinations are typically administered at 2, 4, 6 and 15 months. A final vaccination is now recommended at 4-6 years of age. (27 Sep 1997) |
| duck embryo origin vaccine | See: rabies vaccine. (05 Mar 2000) |
| inactivated polio vaccine | <pharmacology, virology> An inactivated vaccination, administered by injection to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final vaccine is recommended at 4-6 years. (27 Sep 1997) |
| inactivated poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| influenza vaccine | A special vaccine which provides immunity to infection by a variety of Influenza viruses. The vaccine is updated annually due to the constant introduction of new viral strains. Flu vaccination programs are common in the elderly population and any other groups who are at increased risk of viral infection. (27 Sep 1997) |
| oil vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| oral polio vaccine | <drug> A live vaccination, administered orally to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final oral vaccine is recommended at 4-6 years. (27 Sep 1997) |
| oral poliovirus vaccine | An aqueous suspension of live, attenuated strains of poliomyelitis virus (types 1, 2, and 3) given orally for active immunization against poliomyelitis. See: Sabin vaccine. Synonym: poliomyelitis vaccines. (05 Mar 2000) |
| TAB vaccine | A suspension of killed typhoid and paratyphoid A and B bacilli. See: typhoid vaccine. Synonym: TAB vaccine. (05 Mar 2000) |
| tetanus vaccine | See: diphtheria toxoid, tetanus toxoid, and pertussis vaccine. (05 Mar 2000) |
| therapeutic vaccine | An injected therapy consisting of synthetic HIV antigen (for example, gp160) that is administered to people who already have HIV It is supposed to heighten and broaden the immune response to HIV, helping to halt disease progression. (09 Oct 1997) |
| tuberculosis vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| typhoid-paratyphoid A and B vaccine | A suspension of killed typhoid and paratyphoid A and B bacilli. See: typhoid vaccine. Synonym: TAB vaccine. (05 Mar 2000) |
| typhoid vaccine | A suspension of Salmonella typhi inactivated either by heat or by chemical (acetone) with an added preservative; in the U.S., the combined typhoid and paratyphoid A and B vaccine's have been largely replaced by the monovalent typhoid vaccine because of the lack of evidence of effectiveness of paratyphoid A and paratyphoid B ingredients. (05 Mar 2000) |